Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of Wisconsin, Madison
Massachusetts General Hospital
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Gilead Sciences
Universität des Saarlandes
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Case Comprehensive Cancer Center
Gilead Sciences
National Cancer Institute (NCI)
University of Nebraska
University of Nebraska
Hoffmann-La Roche
University of Nebraska
Eastern Cooperative Oncology Group
Celgene
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Rush University Medical Center
Northwestern University
Roswell Park Cancer Institute
City of Hope Medical Center
Hoffmann-La Roche
SWOG Cancer Research Network
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Washington
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Alliance for Clinical Trials in Oncology
Hoffmann-La Roche
Seagen Inc.
Case Comprehensive Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Seagen Inc.
AIDS Malignancy Consortium
Stanford University